Efficacy and Safety of DLBS2411 Compared to Omeprazole in the Management of Gastroesophageal Reflux Disease (GERD)
Phase of Trial: Phase III
Latest Information Update: 06 Feb 2019
Price : $35 *
At a glance
- Drugs DLBS 2411 (Primary) ; Omeprazole
- Indications Gastro-oesophageal reflux
- Focus Registrational; Therapeutic Use
- Sponsors Dexa Medica
- 24 Jan 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 24 Jan 2019 Planned primary completion date changed from 1 Oct 2018 to 1 Oct 2020.
- 24 Jan 2019 Status changed from active, no longer recruiting to recruiting.